Posted in | News

NCS Expects to Close Investment Agreement with CD&R Fund by October 20

-- Transaction to Close As Early As October 20, 2009 --

NCI Building Systems, Inc. (NYSE: NCS) today announced that the major milestones for the completion of its investment agreement with a fund managed by Clayton, Dubilier & Rice (CD&R) have been achieved, and that the Company anticipates closing the transaction as early as October 20, 2009.

NCI reported that as of 5:00 p.m. on October 16, 2009:

  • Holders of more than 99% of the aggregate principal amount of its outstanding 2.125% Convertible Senior Subordinated Notes due 2024 (the "Convertible Notes") have delivered valid tenders, which exceeds the threshold of 95% minimum condition to the offer; and
  • The Company has obtained or expects shortly to obtain the consent of lenders representing 100% of the Company's secured debt for the refinancing of its existing credit facility. 100% consent is a requirement of the CD&R investment. In connection with obtaining this support, the maturity on the refinanced credit facility is to be modified to 4 1/2 years from 5 years.

On October 9, 2009, NCI announced that it had finalized with its lenders terms for a $125 million asset-based revolving credit facility ("ABL") with an additional $50 million accordion feature, and that the Company had confirmed participation from lenders for the full availability under the facility. The ABL, which has the same maturity as the Company's term loan, had been a condition to the closing of the investment agreement.

"We are pleased to report that we have completed another step toward the completion of our investment agreement with CD&R, " said Norman C. Chambers, Chairman, President and Chief Executive Officer. "Once effective, this comprehensive refinancing will significantly reduce our debt and provide us with the resources to support future growth."

Source: http://www.ncilp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.